| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | negative regulation of collagen catabolic process | 6.56e-06 | 5 | 181 | 3 | GO:0010711 | |
| GeneOntologyBiologicalProcess | negative regulation of elastin catabolic process | 6.56e-06 | 5 | 181 | 3 | GO:0060311 | |
| GeneOntologyBiologicalProcess | regulation of elastin catabolic process | 1.30e-05 | 6 | 181 | 3 | GO:0060310 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PCDHGB5 PCDHA1 PCDH20 CRB1 PTPRR PIK3CB PCDHGB4 SPARCL1 CDH3 CDH6 CDH9 ADGRL3 | 2.19e-05 | 313 | 181 | 12 | GO:0098742 |
| GeneOntologyBiologicalProcess | negative regulation of blood vessel remodeling | 2.27e-05 | 7 | 181 | 3 | GO:0060313 | |
| GeneOntologyBiologicalProcess | growth plate cartilage chondrocyte growth | 2.27e-05 | 7 | 181 | 3 | GO:0003430 | |
| GeneOntologyBiologicalProcess | cerebrospinal fluid circulation | 2.49e-05 | 20 | 181 | 4 | GO:0090660 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 4.20e-05 | 187 | 181 | 9 | GO:0007156 | |
| GeneOntologyBiologicalProcess | regulation of collagen catabolic process | 5.37e-05 | 9 | 181 | 3 | GO:0010710 | |
| GeneOntologyBiologicalProcess | negative regulation of extracellular matrix organization | 7.37e-05 | 26 | 181 | 4 | GO:1903054 | |
| GeneOntologyBiologicalProcess | negative regulation of extracellular matrix disassembly | 7.62e-05 | 10 | 181 | 3 | GO:0010716 | |
| GeneOntologyBiologicalProcess | elastin catabolic process | 7.62e-05 | 10 | 181 | 3 | GO:0060309 | |
| GeneOntologyBiologicalProcess | growth plate cartilage chondrocyte development | 7.62e-05 | 10 | 181 | 3 | GO:0003431 | |
| GeneOntologyBiologicalProcess | chondrocyte hypertrophy | 7.62e-05 | 10 | 181 | 3 | GO:0003415 | |
| GeneOntologyBiologicalProcess | negative regulation of collagen metabolic process | 9.96e-05 | 28 | 181 | 4 | GO:0010713 | |
| GeneOntologyBiologicalProcess | chondrocyte development involved in endochondral bone morphogenesis | 1.78e-04 | 13 | 181 | 3 | GO:0003433 | |
| GeneOntologyBiologicalProcess | negative regulation of glycoprotein metabolic process | 1.92e-04 | 33 | 181 | 4 | GO:1903019 | |
| GeneOntologyBiologicalProcess | elastin metabolic process | 2.25e-04 | 14 | 181 | 3 | GO:0051541 | |
| GeneOntologyBiologicalProcess | growth plate cartilage chondrocyte differentiation | 2.25e-04 | 14 | 181 | 3 | GO:0003418 | |
| MousePheno | ruptured lens capsule | 9.71e-06 | 14 | 143 | 4 | MP:0008841 | |
| Domain | FHA | 2.41e-07 | 28 | 181 | 6 | SM00240 | |
| Domain | FHA | 4.59e-07 | 31 | 181 | 6 | PF00498 | |
| Domain | - | 1.17e-06 | 36 | 181 | 6 | 2.60.200.20 | |
| Domain | FHA_dom | 1.17e-06 | 36 | 181 | 6 | IPR000253 | |
| Domain | SMAD_FHA_domain | 1.07e-05 | 52 | 181 | 6 | IPR008984 | |
| Domain | FHA_DOMAIN | 1.12e-05 | 31 | 181 | 5 | PS50006 | |
| Domain | Prot_inh_cystat_CS | 7.20e-05 | 9 | 181 | 3 | IPR018073 | |
| Domain | DUF1220 | 7.20e-05 | 9 | 181 | 3 | SM01148 | |
| Domain | Cadherin_CS | 9.27e-05 | 109 | 181 | 7 | IPR020894 | |
| Domain | NID | 9.34e-05 | 2 | 181 | 2 | PF07292 | |
| Domain | IFP_35_N | 9.34e-05 | 2 | 181 | 2 | PF07334 | |
| Domain | CEP170_C | 9.34e-05 | 2 | 181 | 2 | PF15308 | |
| Domain | CEP170_C | 9.34e-05 | 2 | 181 | 2 | IPR029300 | |
| Domain | Nmi/IFP35_N | 9.34e-05 | 2 | 181 | 2 | IPR009938 | |
| Domain | Nmi/IFP35_dom | 9.34e-05 | 2 | 181 | 2 | IPR009909 | |
| Domain | FAM21 | 9.34e-05 | 2 | 181 | 2 | IPR027308 | |
| Domain | CADHERIN_1 | 1.16e-04 | 113 | 181 | 7 | PS00232 | |
| Domain | Cadherin | 1.16e-04 | 113 | 181 | 7 | PF00028 | |
| Domain | CADHERIN_2 | 1.23e-04 | 114 | 181 | 7 | PS50268 | |
| Domain | - | 1.23e-04 | 114 | 181 | 7 | 2.60.40.60 | |
| Domain | CA | 1.30e-04 | 115 | 181 | 7 | SM00112 | |
| Domain | Cadherin-like | 1.37e-04 | 116 | 181 | 7 | IPR015919 | |
| Domain | DUF1220 | 1.39e-04 | 11 | 181 | 3 | PF06758 | |
| Domain | NBPF_dom | 1.39e-04 | 11 | 181 | 3 | IPR010630 | |
| Domain | NBPF | 1.39e-04 | 11 | 181 | 3 | PS51316 | |
| Domain | Cadherin | 1.53e-04 | 118 | 181 | 7 | IPR002126 | |
| Domain | Cystatin | 1.85e-04 | 12 | 181 | 3 | IPR027214 | |
| Domain | CYSTATIN | 1.85e-04 | 12 | 181 | 3 | PS00287 | |
| Domain | CAP-ZIP_m | 2.78e-04 | 3 | 181 | 2 | PF15255 | |
| Domain | FAM21/CAPZIP | 2.78e-04 | 3 | 181 | 2 | IPR029341 | |
| Domain | MYB_LIKE | 4.87e-04 | 38 | 181 | 4 | PS50090 | |
| Domain | CY | 5.51e-04 | 17 | 181 | 3 | SM00043 | |
| Domain | Cystatin_dom | 6.56e-04 | 18 | 181 | 3 | IPR000010 | |
| Domain | Cystatin | 6.56e-04 | 18 | 181 | 3 | PF00031 | |
| Domain | Myb-like_dom | 1.37e-03 | 6 | 181 | 2 | IPR017877 | |
| Domain | G_PATCH | 1.37e-03 | 23 | 181 | 3 | PS50174 | |
| Domain | G_patch | 1.37e-03 | 23 | 181 | 3 | SM00443 | |
| Domain | G_patch_dom | 1.37e-03 | 23 | 181 | 3 | IPR000467 | |
| Domain | G-patch | 1.37e-03 | 23 | 181 | 3 | PF01585 | |
| Domain | SANT | 1.39e-03 | 50 | 181 | 4 | SM00717 | |
| Domain | SANT/Myb | 1.61e-03 | 52 | 181 | 4 | IPR001005 | |
| Domain | Cadherin_C | 1.76e-03 | 25 | 181 | 3 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 1.76e-03 | 25 | 181 | 3 | IPR000233 | |
| Pubmed | 1.52e-11 | 21 | 192 | 7 | 16079250 | ||
| Pubmed | FRAS1 WASHC2C PPM1E PSD3 GON4L WASHC2A MAP3K4 PXDN STARD9 TLE4 DZIP3 OGFOD1 KATNIP SH3BP5L ANKRD12 R3HDM1 CEP170B ADGRL3 | 1.57e-11 | 407 | 192 | 18 | 12693553 | |
| Pubmed | AKAP6 TOR1AIP2 WASHC2C ANK3 CEP162 TUT7 NOB1 DBNL LMTK2 TFIP11 TACC2 WASHC2A WDFY4 KMT2C PTPRR TLE4 VPS35L DZIP3 ZNF638 AFF1 ANKRD12 PEAK1 USP3 TP53BP1 UTP14C | 1.80e-09 | 1084 | 192 | 25 | 11544199 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CEP162 DBNL PSD3 LMTK2 TSC2 PFKFB2 REEP2 CEP170 FSIP2 DST MTUS1 STARD9 EIF4G1 ZBTB21 KIF14 AKAP13 SH3BP5L PEAK1 PPIP5K2 R3HDM1 PIBF1 CEP170B | 2.91e-09 | 861 | 192 | 22 | 36931259 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DOCK1 CYP4V2 ANK3 PAM16 RABGAP1 TTF1 TRRAP NBPF1 ZNF331 CEP170 ZNF462 KMT2C PTPN4 PTPRB PXDN BRI3BP PTPRR VPS35L ZNF638 AFF1 AKAP13 KATNIP LUZP2 ANKRD12 USP3 SMURF2 CEP170B HTT | 1.53e-08 | 1489 | 192 | 28 | 28611215 |
| Pubmed | ZNF148 ANK3 DBNL MED14 TFIP11 SPAG9 TRRAP SYAP1 MBIP CEP170 KMT2C PDCD11 KIF14 PEAK1 TP53BP1 HTT | 7.99e-08 | 549 | 192 | 16 | 38280479 | |
| Pubmed | GATD3 MIS18BP1 CEP162 MED14 GON4L SPAG9 MORC2 MBIP UBR7 CCNA2 CEP170 DST DZIP3 ZNF638 KIF14 PIBF1 USP3 | 1.30e-07 | 645 | 192 | 17 | 25281560 | |
| Pubmed | DOCK1 ZNF148 WASHC2C DBNL TACC2 MORC2 SYAP1 IFIT3 EIF4G1 MKI67 ZNF638 AKAP13 BCAR3 HSPB1 TP53BP1 | 1.54e-07 | 503 | 192 | 15 | 16964243 | |
| Pubmed | 1.66e-07 | 3 | 192 | 3 | 1898352 | ||
| Pubmed | 1.66e-07 | 3 | 192 | 3 | 1471486 | ||
| Pubmed | 1.66e-07 | 3 | 192 | 3 | 1778989 | ||
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 1.84e-07 | 10 | 192 | 4 | 22973535 | |
| Pubmed | 6.60e-07 | 4 | 192 | 3 | 10713450 | ||
| Pubmed | 6.60e-07 | 4 | 192 | 3 | 13679380 | ||
| Pubmed | ZNF148 RADX GON4L TFIP11 SPAG9 PPARG MORC2 WASHC2A TRRAP MBIP CCNA2 ZNF462 MRPS10 KMT2C DST MRPS2 TLE4 EIF4G1 ZBTB21 MKI67 ZNF638 PDCD11 R3HDM1 TP53BP1 | 1.34e-06 | 1429 | 192 | 24 | 35140242 | |
| Pubmed | 1.55e-06 | 101 | 192 | 7 | 18519826 | ||
| Pubmed | 1.56e-06 | 16 | 192 | 4 | 27773672 | ||
| Pubmed | Cystatin C Deficiency Increases LPS-Induced Sepsis and NLRP3 Inflammasome Activation in Mice. | 1.64e-06 | 5 | 192 | 3 | 34440840 | |
| Pubmed | 1.64e-06 | 5 | 192 | 3 | 21443774 | ||
| Pubmed | Autophagy dysfunction and regulatory cystatin C in macrophage death of atherosclerosis. | 1.64e-06 | 5 | 192 | 3 | 27079462 | |
| Pubmed | Cystatin C increases in cardiac injury: a role in extracellular matrix protein modulation. | 1.64e-06 | 5 | 192 | 3 | 20489058 | |
| Pubmed | Neuroprotection mediated by cystatin C-loaded extracellular vesicles. | 1.64e-06 | 5 | 192 | 3 | 31367000 | |
| Pubmed | Mouse and rat cystatin C: Escherichia coli production, characterization and tissue distribution. | 1.64e-06 | 5 | 192 | 3 | 8761177 | |
| Pubmed | 1.64e-06 | 5 | 192 | 3 | 14742906 | ||
| Pubmed | 1.64e-06 | 5 | 192 | 3 | 33754041 | ||
| Pubmed | Carminerin contributes to chondrocyte calcification during endochondral ossification. | 1.64e-06 | 5 | 192 | 3 | 16680148 | |
| Pubmed | Evolution of C, D and S-type cystatins in mammals: an extensive gene duplication in primates. | 1.64e-06 | 5 | 192 | 3 | 25329717 | |
| Pubmed | 1.64e-06 | 5 | 192 | 3 | 20472891 | ||
| Pubmed | 1.64e-06 | 5 | 192 | 3 | 23671283 | ||
| Pubmed | Cystatin C stimulates the differentiation of mouse osteoblastic cells and bone formation. | 1.64e-06 | 5 | 192 | 3 | 17592728 | |
| Pubmed | Obesity-Induced Increase in Cystatin C Alleviates Tissue Inflammation. | 1.64e-06 | 5 | 192 | 3 | 32616516 | |
| Pubmed | Transforming growth factor beta regulates cystatin C in serum-free mouse embryo (SFME) cells. | 1.64e-06 | 5 | 192 | 3 | 2241983 | |
| Pubmed | Strong conservation of the expression of cystatin C gene in choroid plexus. | 1.64e-06 | 5 | 192 | 3 | 1636787 | |
| Pubmed | 1.64e-06 | 5 | 192 | 3 | 15450354 | ||
| Pubmed | 1.64e-06 | 5 | 192 | 3 | 10748866 | ||
| Pubmed | 1.64e-06 | 5 | 192 | 3 | 15823274 | ||
| Pubmed | Cystatin C deficiency promotes epidermal dysplasia in K14-HPV16 transgenic mice. | 1.64e-06 | 5 | 192 | 3 | 21085595 | |
| Pubmed | 1.64e-06 | 5 | 192 | 3 | 34914637 | ||
| Pubmed | 1.64e-06 | 5 | 192 | 3 | 16595632 | ||
| Pubmed | 1.64e-06 | 5 | 192 | 3 | 12044447 | ||
| Pubmed | FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor. | 1.64e-06 | 5 | 192 | 3 | 11144350 | |
| Pubmed | Cystatin C triggers neuronal degeneration in a model of multiple system atrophy. | 1.64e-06 | 5 | 192 | 3 | 24405769 | |
| Pubmed | 1.64e-06 | 5 | 192 | 3 | 19773092 | ||
| Pubmed | 1.64e-06 | 5 | 192 | 3 | 24570004 | ||
| Pubmed | Loss of cystatin C regulates permeability and inflammatory pathways in retina. | 1.64e-06 | 5 | 192 | 3 | 36822364 | |
| Pubmed | Dissecting the Genetic Architecture of Cystatin C in Diversity Outbred Mice. | 1.64e-06 | 5 | 192 | 3 | 32467129 | |
| Pubmed | Cystatin C modulates neurodegeneration and neurogenesis following status epilepticus in mouse. | 1.64e-06 | 5 | 192 | 3 | 16242633 | |
| Pubmed | Cystatin C Plays a Sex-Dependent Detrimental Role in Experimental Autoimmune Encephalomyelitis. | 1.64e-06 | 5 | 192 | 3 | 33027652 | |
| Pubmed | pH-dependent and dynamic interactions of cystatin C with heparan sulfate. | 1.64e-06 | 5 | 192 | 3 | 33580179 | |
| Pubmed | CST3 alleviates retinal vascular leakage by regulating the Rap1 signaling pathway. | 1.64e-06 | 5 | 192 | 3 | 39147193 | |
| Pubmed | 1.64e-06 | 5 | 192 | 3 | 24500719 | ||
| Pubmed | Control and expression of cystatin C by mouse decidual cultures. | 1.64e-06 | 5 | 192 | 3 | 11803549 | |
| Pubmed | 1.91e-06 | 149 | 192 | 8 | 22664934 | ||
| Pubmed | 2.11e-06 | 151 | 192 | 8 | 17043677 | ||
| Pubmed | 3.27e-06 | 6 | 192 | 3 | 20889561 | ||
| Pubmed | 3.27e-06 | 6 | 192 | 3 | 26592151 | ||
| Pubmed | 3.27e-06 | 6 | 192 | 3 | 16051881 | ||
| Pubmed | 3.27e-06 | 6 | 192 | 3 | 14607896 | ||
| Pubmed | Epithelial cell-derived cytokines CST3 and GDF15 as potential therapeutics for pulmonary fibrosis. | 3.27e-06 | 6 | 192 | 3 | 29724997 | |
| Pubmed | 3.27e-06 | 6 | 192 | 3 | 25356866 | ||
| Pubmed | Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors. | 3.27e-06 | 6 | 192 | 3 | 16365041 | |
| Pubmed | 3.27e-06 | 6 | 192 | 3 | 11879580 | ||
| Pubmed | 3.27e-06 | 6 | 192 | 3 | 18026102 | ||
| Pubmed | Megalin-mediated endocytosis of cystatin C in proximal tubule cells. | 3.27e-06 | 6 | 192 | 3 | 17462596 | |
| Pubmed | 3.27e-06 | 6 | 192 | 3 | 20352108 | ||
| Pubmed | 3.27e-06 | 6 | 192 | 3 | 15653570 | ||
| Pubmed | Macrophage responses to interferon-gamma are dependent on cystatin C levels. | 3.27e-06 | 6 | 192 | 3 | 19446036 | |
| Pubmed | 3.27e-06 | 6 | 192 | 3 | 11472890 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FRAS1 NOB1 MED14 LMTK2 GRID1 TSC2 WASHC2A TRRAP NBPF1 PIKFYVE KMT2C DST EIF4G1 PDCD11 AKAP13 SH3BP5L WDFY3 SMURF2 CEP170B HTT | 3.62e-06 | 1105 | 192 | 20 | 35748872 |
| Pubmed | TUT7 SPAG9 TTF1 TRRAP CEP170 DST UTP25 ATAD2B EIF4G1 MKI67 ZNF638 PDCD11 KIF14 MVP TP53BP1 | 3.95e-06 | 653 | 192 | 15 | 22586326 | |
| Pubmed | 4.65e-06 | 285 | 192 | 10 | 34369648 | ||
| Pubmed | 5.70e-06 | 7 | 192 | 3 | 31513306 | ||
| Pubmed | 5.70e-06 | 7 | 192 | 3 | 18957217 | ||
| Pubmed | 5.70e-06 | 7 | 192 | 3 | 7835704 | ||
| Pubmed | Cathepsin B degrades amyloid-β in mice expressing wild-type human amyloid precursor protein. | 5.70e-06 | 7 | 192 | 3 | 23024364 | |
| Pubmed | 5.70e-06 | 7 | 192 | 3 | 21300820 | ||
| Pubmed | 5.70e-06 | 7 | 192 | 3 | 8879495 | ||
| Pubmed | 5.70e-06 | 7 | 192 | 3 | 27693425 | ||
| Pubmed | 5.70e-06 | 7 | 192 | 3 | 10229662 | ||
| Pubmed | 5.70e-06 | 7 | 192 | 3 | 18681831 | ||
| Pubmed | Isolation of cystatin C via functional cloning of astrocyte differentiation factors. | 5.70e-06 | 7 | 192 | 3 | 15509901 | |
| Pubmed | NBPF8 FRAS1 NBPF12 MED14 PFKFB2 NBPF11 NBPF1 ZNF462 DST STARD9 NBPF9 NBPF10 L3HYPDH | 6.26e-06 | 513 | 192 | 13 | 25798074 | |
| Pubmed | TOR1AIP2 ANK3 CEP162 PPM1E PSD3 LMTK2 SLC6A15 SPAG9 ADD2 PTPN4 PTPRB MTUS1 PTPRR MKI67 ZNF638 KIF14 PEAK1 PIBF1 YME1L1 | 6.37e-06 | 1049 | 192 | 19 | 27880917 | |
| Pubmed | 6.51e-06 | 233 | 192 | 9 | 37704626 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ZNF148 WASHC2C MED14 TFIP11 SPAG9 MORC2 TRRAP SYAP1 TLE4 EIF4G1 ZBTB21 MKI67 ZNF638 AFF1 HSPB1 TP53BP1 | 7.06e-06 | 774 | 192 | 16 | 15302935 |
| Pubmed | TOR1AIP2 FRAS1 ZNF148 ANK3 FRS2 PSD3 SLC6A15 TFIP11 PAM16 PFKM WASHC2A ADD2 MRPS10 BRI3BP MRPS2 PDCD11 AKAP13 DNAJC1 PEAK1 PIBF1 ITM2B YME1L1 TP53BP1 | 8.73e-06 | 1487 | 192 | 23 | 33957083 | |
| Pubmed | 9.09e-06 | 8 | 192 | 3 | 20093401 | ||
| Pubmed | Genomic cloning, physical mapping, and expression of human type 2 cystatin genes. | 9.09e-06 | 8 | 192 | 3 | 7690606 | |
| Pubmed | 9.09e-06 | 8 | 192 | 3 | 11856874 | ||
| Pubmed | 9.09e-06 | 8 | 192 | 3 | 9310336 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TOR1AIP2 CUL1 GATD3 PDSS2 MIS18BP1 PCLO TUT7 PAM16 TSC2 TACC2 SPAG9 RABGAP1 PFKM SYAP1 PIKFYVE MRPS10 DST MRPS2 PDCD11 DNAJC1 R3HDM1 YME1L1 HSPB1 | 9.61e-06 | 1496 | 192 | 23 | 32877691 |
| Pubmed | AKAP6 DOCK1 TOR1AIP2 GATD3 ZNF148 ANK3 FRS2 TTF1 SIRT4 CCNA2 ZNF331 CEP170 KMT2C DST VPS35L ZBTB21 ZNF638 ANKRD12 SMURF2 HSPB1 TP53BP1 | 1.07e-05 | 1293 | 192 | 21 | 15342556 | |
| Pubmed | WASHC2C ANK3 SLC6A15 WASHC2A ADD2 PIKFYVE KIF14 PIBF1 CEP170B | 1.18e-05 | 251 | 192 | 9 | 29778605 | |
| Pubmed | 1.22e-05 | 26 | 192 | 4 | 9226367 | ||
| Pubmed | Translational deregulation in PDK-1-/- embryonic stem cells. | 1.36e-05 | 9 | 192 | 3 | 16166629 | |
| Pubmed | 1.36e-05 | 9 | 192 | 3 | 12672969 | ||
| Pubmed | Induced expression of cathepsins and cystatin C in a murine model of demyelination. | 1.36e-05 | 9 | 192 | 3 | 17086443 | |
| Pubmed | 1.42e-05 | 94 | 192 | 6 | 32062451 | ||
| Pubmed | 1.71e-05 | 263 | 192 | 9 | 34702444 | ||
| Pubmed | Direct mapping of seven genes encoding human type 2 cystatins to a single site located at 20p11.2. | 1.93e-05 | 10 | 192 | 3 | 7896273 | |
| Interaction | LCA5 interactions | CEP162 GPATCH1 TFIP11 CEP170 BRI3BP MTUS1 KIF14 PIBF1 CEP170B | 3.03e-06 | 125 | 191 | 9 | int:LCA5 |
| Interaction | YWHAZ interactions | CUL1 CCDC134 CEP162 PSD3 TSC2 TACC2 PFKFB2 PFKM REEP2 MAP3K4 CEP170 FSIP2 PTPN4 DST MTUS1 STARD9 ZBTB21 ZNF638 KIF14 AKAP13 KATNIP SH3BP5L WDFY3 PEAK1 PPIP5K2 R3HDM1 CEP170B HSPB1 TP53BP1 HTT | 7.00e-06 | 1319 | 191 | 30 | int:YWHAZ |
| Cytoband | 1q21.1 | 1.37e-04 | 62 | 192 | 4 | 1q21.1 | |
| GeneFamily | Neuroblastoma breakpoint family | 1.99e-10 | 23 | 131 | 7 | 662 | |
| GeneFamily | Cystatins, type 2 | 1.94e-04 | 16 | 131 | 3 | 965 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 5.18e-04 | 22 | 131 | 3 | 579 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 5.86e-04 | 53 | 131 | 4 | 532 | |
| GeneFamily | WASH complex | 7.67e-04 | 6 | 131 | 2 | 1331 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 1.18e-03 | 29 | 131 | 3 | 396 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.81e-03 | 9 | 131 | 2 | 1230 | |
| GeneFamily | Tudor domain containing | 2.41e-03 | 37 | 131 | 3 | 780 | |
| GeneFamily | Small heat shock proteins | 2.75e-03 | 11 | 131 | 2 | 585 | |
| GeneFamily | CD molecules|Type II classical cadherins | 3.86e-03 | 13 | 131 | 2 | 1186 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK1 CUL1 ZNF148 PSD3 SPAG9 RABGAP1 TRRAP MAP3K4 CEP170 PIKFYVE PTPN4 DST TLE4 ATAD2B ZNF638 KIF14 AFF1 AKAP13 WDFY3 BCAR3 PPIP5K2 R3HDM1 PIBF1 SMURF2 TP53BP1 | 3.50e-09 | 856 | 190 | 25 | M4500 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | CUL1 ZNF148 PSD3 CEP170 PIKFYVE DST MTUS1 TLE4 MKI67 ZNF638 KIF14 AFF1 WDFY3 BCAR3 PPIP5K2 | 5.84e-09 | 300 | 190 | 15 | M8702 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | CUL1 ZNF148 RABGAP1 TRRAP CEP170 PIKFYVE DST TLE4 ATAD2B ZNF638 KIF14 AFF1 BCAR3 R3HDM1 PIBF1 SMURF2 | 3.28e-07 | 466 | 190 | 16 | M13522 |
| Coexpression | JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN | 1.28e-06 | 48 | 190 | 6 | MM529 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 7.67e-08 | 177 | 191 | 9 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | Control-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.09e-07 | 144 | 191 | 8 | 984470ff6ddce4c743e2db78fa98dae055aaa273 | |
| ToppCell | Severe-Myeloid-Mast-|Severe / Condition, Lineage, Cell class and cell subclass | 2.21e-07 | 145 | 191 | 8 | ce307d45425a5191882078f049f85477eec40b69 | |
| ToppCell | Severe-Myeloid-Mast|Severe / Condition, Lineage, Cell class and cell subclass | 2.21e-07 | 145 | 191 | 8 | e0bfd2ffdbd6c197ef0a04e983396ebd87ef7127 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.48e-07 | 167 | 191 | 8 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_1|Classical_Monocyte / Disease condition and Cell class | 9.23e-07 | 175 | 191 | 8 | 35ea2ed93538e6bf803029fcf7d9243f93e7733d | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_1|COVID-19_Severe / Disease condition and Cell class | 1.19e-06 | 181 | 191 | 8 | 0d07a67e8ee3bca687b378afbc4044434e63556d | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.40e-06 | 185 | 191 | 8 | b4af9ae4c358b48357cb135b740266e1652d886a | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.00e-06 | 194 | 191 | 8 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.00e-06 | 194 | 191 | 8 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_9|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.08e-06 | 195 | 191 | 8 | dd28c63b53f2a97e3fac127294a465870dc371b3 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_9|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.08e-06 | 195 | 191 | 8 | d6ff38535898f90be6719cd5152291f2f4f8a746 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.33e-06 | 198 | 191 | 8 | f261a37dd07976548b897af86df1d1a0dc069889 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.41e-06 | 199 | 191 | 8 | 9940f347973bf976ee23fb4b1cf1f349d96c21df | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 2.41e-06 | 199 | 191 | 8 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.41e-06 | 199 | 191 | 8 | 47466253069d4b1b8f13ce3210f434e60753b38a | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 2.41e-06 | 199 | 191 | 8 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Severe-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.48e-06 | 140 | 191 | 7 | 683ee5e103f0c68cbbec019249404d381dbc39f3 | |
| ToppCell | Mild/Remission-B_naive-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.86e-06 | 143 | 191 | 7 | bd3f5fbd4e9e4dc414682db5607494f3ce988deb | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.87e-06 | 155 | 191 | 7 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.06e-06 | 164 | 191 | 7 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | Mild-Myeloid-Mast|Mild / Condition, Lineage, Cell class and cell subclass | 7.34e-06 | 165 | 191 | 7 | 5fa9552c37890c5cc7e672a47038aebba2413cb4 | |
| ToppCell | Mild-Myeloid-Mast-|Mild / Condition, Lineage, Cell class and cell subclass | 7.34e-06 | 165 | 191 | 7 | 93d3909a0f5f43d473d5005c842d7d73e25eceed | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.95e-06 | 167 | 191 | 7 | 0aa1973141a2437df24c9857cd50ff3dfc7673c0 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.95e-06 | 167 | 191 | 7 | 774f3264318b002d0df5d06d41d645366038d0bf | |
| ToppCell | Severe-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.46e-06 | 111 | 191 | 6 | 7021009545178fac1f19f3c429bfedb2f38b680d | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.63e-06 | 172 | 191 | 7 | ba36581ae339191a12a6d3ead39eaf69d78be10e | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.08e-05 | 175 | 191 | 7 | c58a1f02d1e559d3638fe1500e960e82a8a7187b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.16e-05 | 177 | 191 | 7 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.25e-05 | 179 | 191 | 7 | 40441de2d679733ecbf2145fabc3ed65a53310eb | |
| ToppCell | COVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class | 1.39e-05 | 182 | 191 | 7 | 877b6e611626628e709568747512f2827ebb2795 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-05 | 182 | 191 | 7 | 4cd5eb13f78f4f377932c50ac2acb4ac0cd14c12 | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.44e-05 | 183 | 191 | 7 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.49e-05 | 184 | 191 | 7 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 184 | 191 | 7 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-05 | 186 | 191 | 7 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.60e-05 | 186 | 191 | 7 | 4fe8e0bf74c7dbf73634cafdacad89020d2634d0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.66e-05 | 187 | 191 | 7 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-05 | 187 | 191 | 7 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-05 | 188 | 191 | 7 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | Severe-B_intermediate-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.75e-05 | 126 | 191 | 6 | 42a0bdbe18ef85146cac4e86b2b27d0b3b20d8a2 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.77e-05 | 189 | 191 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.83e-05 | 190 | 191 | 7 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | facs-Thymus-Epithelium-3m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-05 | 191 | 191 | 7 | d2311a5b0cf186839000f9f272b6fbc2270ddb44 | |
| ToppCell | facs-Thymus-Epithelium-3m-Endothelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-05 | 191 | 191 | 7 | 6676ef9aeb890668cb69e67865404061b8467c25 | |
| ToppCell | facs-Thymus-Epithelium-3m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-05 | 191 | 191 | 7 | a157cee0fbc9dce64308128c3578e7327fa178b7 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.96e-05 | 192 | 191 | 7 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.96e-05 | 192 | 191 | 7 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.96e-05 | 192 | 191 | 7 | 24797e80b1f5b3ea5a0410caaf57ccf2ae9d716e | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 2.10e-05 | 194 | 191 | 7 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 2.10e-05 | 194 | 191 | 7 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_atypical-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.10e-05 | 194 | 191 | 7 | b8f05efb16fbed7317019efc3da7f97f81e90972 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-05 | 194 | 191 | 7 | effd38e51062b225ecabc7e1c50154e65495d559 | |
| ToppCell | PBMC-Mild|PBMC / Compartment, Disease Groups and Clusters | 2.10e-05 | 194 | 191 | 7 | d1366b169d14011194e61d16b6b0953349febc78 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.17e-05 | 195 | 191 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-05 | 196 | 191 | 7 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | Severe-B_intermediate-10|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.39e-05 | 198 | 191 | 7 | dfae26c3513a82bb7cb8dadbfcea2a1f420b1bab | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.39e-05 | 198 | 191 | 7 | a11ac83dbd69d1c068971266d7c7343d114a6294 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-CD4+_CTL|Int-URO / Disease, condition lineage and cell class | 2.39e-05 | 198 | 191 | 7 | 717735d755745439f97ba1b71785c73945dfa9c5 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.39e-05 | 198 | 191 | 7 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.47e-05 | 199 | 191 | 7 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.55e-05 | 200 | 191 | 7 | 8c803a0ce25e140b46036f6aabefc5502601f408 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.55e-05 | 200 | 191 | 7 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.55e-05 | 200 | 191 | 7 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.55e-05 | 200 | 191 | 7 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-05 | 200 | 191 | 7 | 553e9612874480f4d2a45671462e266cd0a09321 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_and_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.49e-05 | 149 | 191 | 6 | 3904f8ce9078de238600ceceee0116af52256a1c | |
| ToppCell | COVID-19_Mild|World / 5 Neutrophil clusters in COVID-19 patients | 5.02e-05 | 152 | 191 | 6 | 2ff0980dfd8d430cca14649151d856edef115720 | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 5.02e-05 | 152 | 191 | 6 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 6.01e-05 | 157 | 191 | 6 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.44e-05 | 159 | 191 | 6 | e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.11e-05 | 100 | 191 | 5 | 20675fc2ffc5ab63047d38da083b50d470f3db19 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.11e-05 | 100 | 191 | 5 | 1de3895e16f14ff32b901b18ce14d965afaa7e76 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.11e-05 | 100 | 191 | 5 | ff1bdb511700a041a90034d1d30dfc25f51d6c82 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.15e-05 | 162 | 191 | 6 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-05 | 162 | 191 | 6 | 465cb483f41023d6125ea147e16f404d8e8dc9bb | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.39e-05 | 163 | 191 | 6 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 7.65e-05 | 164 | 191 | 6 | 362c16ed7fb37bf16601fd5e059d3f3e2ed692b4 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-05 | 164 | 191 | 6 | 758e85e2f5e7236b345e16c78344d5e0bf17d8dc | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.18e-05 | 166 | 191 | 6 | a42268a02a89fc97272e45c4cbe21acf04b7428c | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_dendritic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.18e-05 | 166 | 191 | 6 | 479391aa6c09aa070b716128ab51b8fec0aea22d | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.73e-05 | 168 | 191 | 6 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | Dividing_Macrophages-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 9.02e-05 | 169 | 191 | 6 | bc859a103cad567caf50c3c3882d2d2017807c73 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.63e-05 | 171 | 191 | 6 | 9be3554626408bb897d1f1c43b3ab4a92651f2e2 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.63e-05 | 171 | 191 | 6 | 05014cf6746e6663e376fdd681f1b43a7081c603 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.63e-05 | 171 | 191 | 6 | d6114db2292fbb27b39d090d51fd305a135b1ccf | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.63e-05 | 171 | 191 | 6 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.63e-05 | 171 | 191 | 6 | 6a2f88c2a62cb2f69797804e24eb1137a3e148de | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.63e-05 | 171 | 191 | 6 | 121e63ca281ad765d76c2afb3b4d441329b47f81 | |
| ToppCell | E15.5-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.94e-05 | 172 | 191 | 6 | a8b33d8ebc56e442a2ad6ac7dafd0c887571bd95 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.94e-05 | 172 | 191 | 6 | eba1568d4307e91c94fc616549057cbed8df5840 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.03e-04 | 173 | 191 | 6 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-04 | 174 | 191 | 6 | 65147b0f8c2ccadd5685430d31081520c157536a | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-04 | 175 | 191 | 6 | d43ae33a6256606ce848247cad32d74f21b38988 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-04 | 176 | 191 | 6 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | wk_08-11-Epithelial-PNS-FGFBP2+_Neural_progenitor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.16e-04 | 177 | 191 | 6 | 15a5c96ea840376e54933ebe7a8334a11d9ce411 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-04 | 177 | 191 | 6 | e1e45956887371b1c18f1eb479dd930031497520 | |
| ToppCell | facs-Aorta-Heart-24m-Endothelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 177 | 191 | 6 | c6b955765aee8a196fcf4f7bb16139c95b76dc4e | |
| ToppCell | droplet-Marrow|droplet / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 177 | 191 | 6 | 0b8a1496c078874def0bfca0268136f1a84b82fd | |
| ToppCell | Severe-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.20e-04 | 178 | 191 | 6 | b7374a97c51239782bed658381a02cb1b3d9bf66 | |
| Disease | cystatin-SN measurement | 1.89e-05 | 9 | 182 | 3 | EFO_0008106 | |
| Disease | urate measurement, bone density | AKAP6 FRAS1 CYP2C8 DDX12P ADGRB3 PSD3 GRID1 PAM16 FSIP2 FNDC1 KIF14 LUZP2 PEAK1 | 1.32e-04 | 619 | 182 | 13 | EFO_0003923, EFO_0004531 |
| Disease | cystatin-D measurement | 1.47e-04 | 17 | 182 | 3 | EFO_0008103 | |
| Disease | Chediak-Higashi syndrome (implicated_via_orthology) | 2.25e-04 | 4 | 182 | 2 | DOID:2935 (implicated_via_orthology) | |
| Disease | Abnormality of refraction | AKAP6 ANK3 PCLO PCDHA1 ZNF462 RGS18 PTPRR AFF1 PLAG1 AKAP13 RORB PEAK1 ADGRL3 | 2.97e-04 | 673 | 182 | 13 | HP_0000539 |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 3.48e-04 | 150 | 182 | 6 | EFO_0004611, EFO_0020947 | |
| Disease | triglycerides in LDL measurement | 4.00e-04 | 56 | 182 | 4 | EFO_0022320 | |
| Disease | airway responsiveness measurement | 4.25e-04 | 24 | 182 | 3 | EFO_0006897 | |
| Disease | triglycerides in IDL measurement | 4.58e-04 | 58 | 182 | 4 | EFO_0022149 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 4.77e-04 | 222 | 182 | 7 | EFO_0008317, EFO_0020943 | |
| Disease | Intellectual Disability | 4.87e-04 | 447 | 182 | 10 | C3714756 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 5.16e-04 | 225 | 182 | 7 | EFO_0008317, EFO_0020947 | |
| Disease | free cholesterol in very large VLDL measurement | 5.55e-04 | 61 | 182 | 4 | EFO_0022274 | |
| Disease | treatment-resistant hypertension | 5.88e-04 | 109 | 182 | 5 | EFO_1002006 | |
| Disease | triglycerides in medium LDL measurement | 5.91e-04 | 62 | 182 | 4 | EFO_0022322 | |
| Disease | lipoprotein A measurement | 6.65e-04 | 112 | 182 | 5 | EFO_0006925 | |
| Disease | triglycerides in small LDL measurement | 7.07e-04 | 65 | 182 | 4 | EFO_0022323 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 7.37e-04 | 239 | 182 | 7 | EFO_0008317, EFO_0020945 | |
| Disease | total lipids in small VLDL | 7.93e-04 | 67 | 182 | 4 | EFO_0022148 | |
| Disease | triglycerides in very small VLDL measurement | 8.38e-04 | 68 | 182 | 4 | EFO_0022144 | |
| Disease | free cholesterol in large VLDL measurement | 8.38e-04 | 68 | 182 | 4 | EFO_0022265 | |
| Disease | synophrys measurement | 8.38e-04 | 68 | 182 | 4 | EFO_0007906 | |
| Disease | factor XI measurement | 1.03e-03 | 8 | 182 | 2 | EFO_0004694 | |
| Disease | cystatin-SA measurement | 1.03e-03 | 8 | 182 | 2 | EFO_0008105 | |
| Disease | sarcoma (is_implicated_in) | 1.03e-03 | 8 | 182 | 2 | DOID:1115 (is_implicated_in) | |
| Disease | Kartagener Syndrome | 1.31e-03 | 35 | 182 | 3 | C0022521 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 1.31e-03 | 35 | 182 | 3 | C4551906 | |
| Disease | Polynesian Bronchiectasis | 1.31e-03 | 35 | 182 | 3 | C4317124 | |
| Disease | gout | 1.41e-03 | 196 | 182 | 6 | EFO_0004274 | |
| Disease | oppositional defiant disorder measurement | 1.42e-03 | 36 | 182 | 3 | EFO_0007679 | |
| Disease | Global developmental delay | 1.44e-03 | 133 | 182 | 5 | C0557874 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.01e-03 | 86 | 182 | 4 | EFO_0008595, EFO_0020945 | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 2.18e-03 | 88 | 182 | 4 | EFO_0803332 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.24e-03 | 215 | 182 | 6 | EFO_0008317, EFO_0008591 | |
| Disease | triglycerides in large LDL measurement | 2.38e-03 | 43 | 182 | 3 | EFO_0022319 | |
| Disease | Abruptio Placentae | 2.40e-03 | 12 | 182 | 2 | EFO_1001754 | |
| Disease | gait measurement | 2.43e-03 | 150 | 182 | 5 | EFO_0007680 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 2.47e-03 | 91 | 182 | 4 | EFO_0004611, EFO_0005271 | |
| Disease | glioblastoma (is_marker_for) | 2.54e-03 | 44 | 182 | 3 | DOID:3068 (is_marker_for) | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 2.75e-03 | 224 | 182 | 6 | EFO_0004530, EFO_0008317 | |
| Disease | smoking status measurement, ulcerative colitis | 2.82e-03 | 13 | 182 | 2 | EFO_0000729, EFO_0006527 | |
| Disease | Primary Ciliary Dyskinesia | 3.07e-03 | 47 | 182 | 3 | C4551720 | |
| Disease | urinary bladder cancer (biomarker_via_orthology) | 3.28e-03 | 14 | 182 | 2 | DOID:11054 (biomarker_via_orthology) | |
| Disease | triglyceride measurement, alcohol consumption measurement | 3.59e-03 | 101 | 182 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | Alzheimer disease, polygenic risk score | 3.61e-03 | 586 | 182 | 10 | EFO_0030082, MONDO_0004975 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 3.76e-03 | 166 | 182 | 5 | EFO_0004530, EFO_0004611 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 3.87e-03 | 51 | 182 | 3 | EFO_0022302 | |
| Disease | response to methotrexate | 4.29e-03 | 16 | 182 | 2 | GO_0031427 | |
| Disease | fourth ventricle volume measurement | 4.29e-03 | 16 | 182 | 2 | EFO_0010303 | |
| Disease | total lipids in medium VLDL | 4.54e-03 | 54 | 182 | 3 | EFO_0022153 | |
| Disease | plasminogen activator inhibitor 1 measurement | 4.54e-03 | 54 | 182 | 3 | EFO_0004792 | |
| Disease | triglycerides in medium VLDL measurement | 4.79e-03 | 55 | 182 | 3 | EFO_0022155 | |
| Disease | depressive symptom measurement | 5.12e-03 | 426 | 182 | 8 | EFO_0007006 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 5.29e-03 | 57 | 182 | 3 | EFO_0022284 | |
| Disease | cholesteryl ester measurement | 5.36e-03 | 257 | 182 | 6 | EFO_0010351 | |
| Disease | Nuclear non-senile cataract | 5.42e-03 | 18 | 182 | 2 | C1112705 | |
| Disease | Nuclear cataract | 5.42e-03 | 18 | 182 | 2 | C0392557 | |
| Disease | triglycerides to total lipids in small LDL percentage | 5.82e-03 | 59 | 182 | 3 | EFO_0022337 | |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 5.82e-03 | 59 | 182 | 3 | EFO_0001663, MONDO_0005148 | |
| Disease | phospholipids in VLDL measurement | 5.82e-03 | 59 | 182 | 3 | EFO_0022301 | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 5.82e-03 | 59 | 182 | 3 | EFO_0022248 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 6.09e-03 | 264 | 182 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 6.10e-03 | 60 | 182 | 3 | EFO_0021898 | |
| Disease | total lipids in VLDL measurement | 6.10e-03 | 60 | 182 | 3 | EFO_0022314 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PNFHKLENKSSIETK | 211 | Q9BXT4 | |
| NINNTPKHFRKDVDV | 111 | Q15361 | |
| PEEALKHEKFTIQLQ | 106 | Q5SW79 | |
| TKLAPEEHVNTKVQQ | 301 | Q5W0A0 | |
| KLNVEAVNTHRDKPT | 436 | O60825 | |
| QHQLKDVKPTPDFVE | 56 | Q8NEF3 | |
| SNPSVEEKLEHLEKQ | 216 | Q8WY22 | |
| QFSQILEEHKAKVTE | 231 | Q7L8J4 | |
| DDSQKPLEIKDNHVE | 356 | Q8NHY0 | |
| KELFTNNDPKVIAQH | 541 | O75815 | |
| ENHSEPSHQDVIKVK | 761 | Q6ZN30 | |
| PSHQDVIKVKEEFTD | 766 | Q6ZN30 | |
| HEKRVPQEQADAAKF | 271 | O60242 | |
| PEDIQHDKKAFLNDS | 191 | O95264 | |
| PVTHRTDDNIQKVKD | 66 | Q3ZCU0 | |
| LKAETEHNKEVAPQV | 991 | Q12802 | |
| PVVFTVKHIKQSEEN | 786 | Q9HAR2 | |
| EKVKEHQASLDVNNP | 246 | P10632 | |
| IHTIKVNDPETAVKE | 226 | Q6JQN1 | |
| VKSFDSKNHPEVLNI | 56 | O43184 | |
| NKKSDVEVQTENHAP | 86 | Q8N302 | |
| NAKIKDEDHSPTFEN | 621 | Q6UB98 | |
| PEEALKHEKYTSQLQ | 106 | Q9Y4F5 | |
| HKINSDVQPFIKEKT | 291 | Q86YH6 | |
| TLHPDKNKDENAETQ | 91 | Q96KC8 | |
| LKPEEEHQTDEKQFQ | 161 | Q5SZJ8 | |
| DVVPEDKFQETLHLK | 36 | O43918 | |
| TRIPDQKFNEHIKDD | 231 | Q15032 | |
| HQSFPNEENDVDKIK | 196 | Q13637 | |
| LNDIASKPSQEHIFK | 301 | P20702 | |
| PQDFEKEIAKLHQQH | 181 | P29074 | |
| DSTKEDIQIQFLPDH | 296 | Q96RS6 | |
| LQTLHQKPTEEKEFK | 186 | Q9NQX1 | |
| VEIEDINDHTPKFTQ | 121 | Q9UN71 | |
| DAPNKSEISKHIEVQ | 306 | O60271 | |
| KQPEEHNFSDTKIIS | 206 | Q6NSI4 | |
| HENSNLVPKDERFNK | 871 | Q8N7Z5 | |
| HFQVVNEETPKDKVL | 391 | Q9Y3P9 | |
| SIDEHFQPKQIVKSL | 186 | Q8N543 | |
| QKVPQASKDLFHLDE | 361 | Q8N6Y1 | |
| KEITVEHPDTKQVYN | 386 | Q15058 | |
| SQKVDSQTIPKHVFE | 946 | P23467 | |
| HEAFNIVKNKTEPVI | 251 | Q96PR1 | |
| EFVGVSHLKQEPQKV | 96 | Q9ULX3 | |
| KDSKPNVVSDNVFHI | 2536 | Q86XX4 | |
| FKDPLKQRESEHEQE | 1736 | Q8NEZ4 | |
| ETFTPNRVEKKKLQH | 146 | Q6P0N0 | |
| NIKAATNHVTPEEKE | 146 | Q9P2W1 | |
| QKLEDPFQKHLNSTE | 16 | Q9GZQ4 | |
| DPANIVHDFNKKLTA | 141 | Q9Y287 | |
| AFDKSEAQVLNPEHK | 356 | Q9ULD2 | |
| PVTFVKSEEKTQEEH | 91 | Q0VAK6 | |
| DPDKIKTQLAQHKEF | 6736 | Q03001 | |
| APADHSILVDQKNEK | 611 | O60303 | |
| EVQNIQPDKDSAHKE | 1171 | A6NM62 | |
| KVFPHAEISQSDKKE | 696 | Q9ULI0 | |
| VEAHVDQKNKVVTTP | 226 | A0A0B4J2D5 | |
| KILEESSQEQKPEHG | 6821 | Q5CZC0 | |
| KQQSSPLVNKEEEHA | 711 | Q9BRR8 | |
| APEEQKHDLLKSQVQ | 1256 | Q9Y6V0 | |
| DDPKVAEQVLQQKEH | 86 | P80217 | |
| LKDQTDFEHRIPKEQ | 726 | P08237 | |
| FSQAKQKSHLVDPEI | 1556 | Q9H792 | |
| HSKKIANVPNTEEDE | 146 | P16499 | |
| VQVENKDPKRSHFVL | 226 | O00625 | |
| QQPFDDSLEHEKLTV | 321 | O15264 | |
| FNDVDKSEDLPSHQK | 636 | Q8IWU2 | |
| VNHFAPDELTVKTKD | 101 | P04792 | |
| EHKLQDSVPENKGIS | 3076 | P46013 | |
| KHHTSKIQEFADLPQ | 286 | A4D2B8 | |
| VEIEDINDHTPKFTQ | 121 | Q9Y5G0 | |
| NQPHKNINITFEEDK | 221 | Q3BBV0 | |
| NVKSHPEIQFAEINK | 621 | Q86Y13 | |
| HFEVNDRKDPQETAK | 546 | Q14764 | |
| IDENDVSKPLQIFHD | 361 | O60244 | |
| LEPTHNKQDFADAKE | 421 | Q9Y6X9 | |
| QDKEKNQEIHLSPIT | 261 | Q15256 | |
| VFHVEVKVKDINDNP | 116 | Q9Y5I3 | |
| VNPDEAVKVVSDHLK | 441 | Q8WY54 | |
| KKQLINPHVELQFSD | 1801 | Q9Y2I7 | |
| HSEGKQIKNLPEETF | 1726 | P42858 | |
| DQHKTKFGISETQEL | 316 | Q6E213 | |
| NKHENIPFEDKTASV | 116 | Q96PB1 | |
| HQEIFEKEFKPTDIS | 1706 | Q14185 | |
| QEDVDPQKVAFLLHK | 56 | Q8N0S6 | |
| VAEAIRNHKNEKPEF | 391 | Q6ZN84 | |
| DLNEQFKKHLTNSEP | 516 | Q13616 | |
| DTVPDNHRNKFKVIN | 11 | Q8WU20 | |
| KEAAASLPKHQQVES | 1101 | Q4ZHG4 | |
| HPEKQFSTDVLKQAI | 186 | O14879 | |
| EVEKVKPQSEKVHQT | 666 | Q3T8J9 | |
| RKKIFQEPKSAHQVE | 751 | Q92771 | |
| QVEAKAKDDQTPLHI | 491 | Q12955 | |
| VEDIKSSVKGHPQEN | 316 | Q5TB80 | |
| GSNPEVQKKVDHELD | 346 | Q6ZWL3 | |
| SKHSFPDVTNIVQEK | 421 | Q86X45 | |
| DQGPKTIDQIHKEAE | 996 | Q04637 | |
| EKHQATINFLKTEVE | 106 | Q86TE4 | |
| RDVKKTQIHFDPEVV | 136 | Q9NS73 | |
| VEAHVDQKNKVVTTP | 226 | P0DPI2 | |
| HQETPKEDKEVNLEQ | 861 | Q9ULK0 | |
| PESEFIIKIHDINDN | 141 | P55285 | |
| VEVHNAKTKPREEQF | 161 | P01859 | |
| TKPHQQLKEVSVEER | 1321 | Q6ZMW3 | |
| VLSESEFHVTPEKNK | 6716 | Q8NDH2 | |
| DVKHFSPEDLTVKVQ | 76 | P02489 | |
| LDTCAFHEQPELQKK | 101 | P09228 | |
| LDTCAFHEQPELQKK | 101 | P01037 | |
| KANSKQPAFTIHVDE | 91 | P20248 | |
| HAEKEPEFLNISIQD | 991 | P82279 | |
| LDTCAFHEQPELQKK | 101 | P01036 | |
| KEVFEDKQSVLHNSP | 551 | O00237 | |
| PESEFIIKIHDINDN | 141 | Q9ULB4 | |
| IIKIHDINDNEPKFT | 146 | Q9ULB4 | |
| ISIIVTDQNDHKPKF | 201 | P22223 | |
| QESAVHPREIFKQKE | 251 | Q9UJU6 | |
| VVRNQEEKIKEFHPT | 431 | Q4G0U5 | |
| FQPNDHKTIKETADE | 1376 | Q9Y6R4 | |
| IKNTLPSHKEQDHEQ | 51 | P0DPB5 | |
| KESEADSEVKHQPIF | 116 | A2RTX5 | |
| SQDPFLQHVNKELKE | 186 | Q68CQ4 | |
| QFSNLHVDVPKDLTK | 46 | P82664 | |
| FHDNEKVSEVLPIQK | 601 | Q9C093 | |
| QKVKEEEFPALHLNS | 411 | Q9H2J7 | |
| HPKDKTEDENKQSFL | 81 | Q8NFQ8 | |
| QHTPKVKNNVEIDEF | 51 | B5MCY1 | |
| IQPHKNIKITFEEDK | 186 | Q3BBV2 | |
| NQPHKNIKITFEEDE | 221 | P0DPF3 | |
| NQPHKNIKITFEEDE | 221 | Q6P3W6 | |
| IQPHKNIKITFEEDK | 221 | Q86T75 | |
| IQPHKNIKITFEEDK | 221 | Q5TAG4 | |
| SNQPHKNIKITFEED | 491 | Q5TAG4 | |
| NQPHRKTKITFEEDK | 221 | A0A087WUL8 | |
| KFKHITPLQEQSKEV | 291 | P37231 | |
| EKKLQETPTEANHVQ | 56 | Q86UD5 | |
| FHKVQPQEPKVTDTE | 431 | O43699 | |
| DTVNPDKVDFVHKRV | 236 | Q9Y6E7 | |
| FVEEQHTKKSEAAVP | 111 | Q96A49 | |
| HTPGTDKELVFQDQK | 2076 | Q9P2P6 | |
| ENATALHVKFPENKK | 486 | P42338 | |
| TDFNDKILNEPLKHS | 56 | Q9Y399 | |
| EAVKAQFKINHPDSE | 221 | Q96EM0 | |
| EEVKKNHSIILSAPN | 51 | P32856 | |
| SEDIVLHKNKIPESN | 1701 | Q13023 | |
| PFVQEKTKHKSEVEI | 386 | P35612 | |
| VKVHDKETPQDSLVA | 251 | P51825 | |
| PQDEKLKDAFSHVVE | 96 | Q9H6E4 | |
| HNQELLKVKTEPVDF | 236 | Q6DJT9 | |
| NEVIPQHLLKTFDEK | 606 | Q9HAU4 | |
| VKTHQEIKLDDSNIP | 2921 | A4UGR9 | |
| IHKPEKAFQQSVEQD | 16 | Q14690 | |
| VQLAKFSKQHVPEEH | 596 | Q8IWX7 | |
| EIAQVPKAHVDEFKS | 306 | Q16851 | |
| KLKVNEHGSPVSEDN | 496 | Q9ULJ3 | |
| EPNKVNHIVTTKDDN | 831 | Q9ULJ3 | |
| IEDFSFKEPQKNVHD | 126 | Q9HCG1 | |
| EIFNLLHKNKQPVTD | 186 | Q5TAP6 | |
| DAFIKHQQEPTKDPV | 591 | Q7Z3J2 | |
| IPQSQKDHFKSQAEE | 261 | P0CB47 | |
| QQEPEHGEDTIAKVK | 2466 | Q8IZQ1 | |
| ETRNVEKHQDIPTVK | 131 | P17023 | |
| FVHPTLSNKEKEIDE | 91 | Q9BRK0 | |
| DAPKEVNLDFHTKEV | 146 | Q9NS28 | |
| SVPEKAAQKEDAQRH | 1051 | A0A1B0GUW6 | |
| NSNVEVLHVTKPDKY | 681 | Q04727 | |
| KTELPREHANSKQEE | 221 | Q14515 | |
| EQEFSHSFKENIPVK | 1036 | Q9BX26 | |
| HSFKENIPVKEENIH | 1041 | Q9BX26 | |
| KTLNVPKEHEDNIFT | 721 | Q8WXW3 | |
| AAHTFEDLKNEIKNP | 1181 | Q92626 | |
| EKLQVFKQSHPEIVN | 436 | Q92753 | |
| HQVFLSPNEDVKEKR | 2091 | Q6ZS81 | |
| YENKSLPTEKNIHEI | 51 | Q9NQX6 | |
| LFSHKLQKDNDPDVD | 846 | Q9Y4E1 | |
| HLQVPEKSSQKELEA | 2606 | O95359 | |
| NEHLKENKVADPVDS | 81 | Q12888 | |
| SKLSPEEVQKNYEHL | 66 | Q9Y3D7 | |
| KTKNIPEAHQDAFKT | 256 | Q96TA2 | |
| YEDAQVPLTNHKKSE | 61 | Q9Y6I4 | |
| LFSHKLQKDNDPDVD | 846 | Q641Q2 | |
| KAVKQVQEEDPNTHI | 701 | Q13105 | |
| HQDSTLKEDVPEQGK | 231 | Q8N806 | |
| NDTKQVSREEIHPKE | 2441 | Q96JM2 | |
| KKVAEIHQALNSDPT | 31 | Q96BZ9 | |
| EIKSNHDKNVIPDEV | 526 | Q9UQR1 | |
| QKPFVEKPVSAEDHN | 181 | O43314 | |
| HPDVQTKDDKLKNSV | 661 | Q5VYS8 | |
| IKHEKNATEIQTARP | 51 | Q05940 | |
| EVFLQENKQHLEKTP | 391 | Q9NYI0 | |
| AKPIDKQHTDTVVNF | 2086 | Q9Y4A5 | |
| LKEEISQRFKAHPDQ | 46 | Q9H347 | |
| SDQVLAHPSVKDKFN | 691 | Q9UBB9 | |
| KVELAQSKNDHPTDK | 1791 | Q14966 | |
| VTQENKDQPVISKHE | 106 | Q6SJ96 | |
| PFDQLVQRAAEEKHK | 81 | A2RUC4 | |
| HVRQTKEAPAKLESQ | 1101 | P49815 | |
| LTIHNKINTAEKPFE | 311 | Q86TJ5 | |
| ILKEHSPDEFIKDEQ | 11 | Q13287 |